Subsidiaries
Exports
Sites
GROWTH BEYOND
Our Exports
Pharmazac has built a growing international footprint through the export of pharmaceutical products and dossiers to selected markets worldwide.
Our export activity is based on long-term partnerships, regulatory reliability and a clear understanding of local market needs. Through our international network, we support partners with high-quality pharmaceutical products, flexible cooperation models and consistent supply.
With experience across regulated and emerging markets, Pharmazac continues to expand its presence abroad, aiming to create sustainable value for patients, healthcare systems and business partners.
GLOBAL NETWORK
International Licensing
International Licensing is a core pillar of Pharmazac’s growth strategy.
We develop and offer pharmaceutical dossiers for international markets, supporting our partners with reliable documentation, regulatory know-how and commercially relevant product opportunities.
Our licensing approach is built on transparency, flexibility and long-term collaboration. We focus on products with clear market potential, while working closely with partners to adapt each opportunity to the regulatory and commercial requirements of their territories.
Through international licensing, Pharmazac aims to strengthen its global presence and create partnerships that go beyond a simple transaction.
REGIONAL EXPANSION
Our Subsidiaries
Pharmazac subsidiaries enhance its international presence in SE Europe and strengthen its commercial reach in key markets.
Our subsidiaries allow us to be closer to local healthcare environments, better understand the market dynamics and support our partners with direct, responsive and market-oriented solutions.
This structure reflects our commitment to international development, operational flexibility and long-term growth across selected regions.
STRATEGIC CONTRIBUTOR
DIAGNOZ Plc
DIAGNOZ Plc is a part of Pharmazac’s broader corporate structure and supports the Group’s activities in the field of diagnostics.
Through DIAGNOZ, Pharmazac strengthens its presence in a strategically important healthcare sector, expanding its capabilities beyond traditional pharmaceutical products.
The company contributes to the Group’s vision of offering integrated healthcare solutions, combining scientific expertise, market understanding and a commitment to quality.
